Hydrogen Gas Does Not Ameliorate Renal Ischemia Reperfusion Injury in a Preclinical Model.
Hosgood SA, Moore T, Qurashi M, Adams T, Nicholson ML · Artificial organs · 2018
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
The study did not find a clear primary benefit from molecular hydrogen under the conditions tested.
Hydrogen ischemia-reperfusion study 2018 hosgood: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This in vitro or cellular study examined Hydrogen Gas Does Not Ameliorate Renal ischemia-reperfusion injury (damage that can occur when blood flow returns after a period of low oxygen) in a Preclinical Model. The abstract describes Cell culture / in vitro model.
Publication: Hosgood SA, Moore T, Qurashi M, Adams T, Nicholson ML, Artificial organs, 2018.
What the researchers studied
The aim of this study was to examine the effects of hydrogen gas administered during reperfusion in a preclinical model of kidney ischemia reperfusion…
What effects did molecular hydrogen have?
Observed hydrogen effects: In renal transplantation, ischemia-reperfusion injury (damage that can occur when blood flow returns after a period of low oxygen) impairs early graft function and can reduce long term graft survival. Hydrogen has antioxidant and anti-inflammatory properties that can reduce the effects of ischemic injury.
Why these findings matter
This study did not show a clear primary therapeutic benefit under the tested conditions. That is useful evidence because it helps define where hydrogen may not work, whether the dose or timing matters, and what future studies need to test differently.
How strong is this evidence?
This is preclinical animal evidence. It can show biological effects in a whole living system, but human effectiveness and dosing still require clinical trials. Randomization: Yes.
Technical study details
- Publication type: Animal study
- Evidence type: Preclinical animal evidence
- Research model or population: Ex vivo porcine kidney ischemia-reperfusion model
- Randomized: Yes
- Hydrogen method: Other or not reported
- Hydrogen flow rate: 108 mL/min
- Dose or treatment amount: 693 mL
Limitations and safety
Important limitations: Laboratory findings may not translate directly to living organisms or clinical outcomes.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.